Cell and Gene Logistics

  1. Challenges In Manufacturing TIL For Clinical Trials 3/6/2025

    Tumor-infiltrating lymphocyte cell therapy shows promise for treating solid tumors, but its complex manufacturing profile brings a unique set of issues. Here are some things to watch out for.

  2. 4 Key Steps To Build Supply Chains For Later-Stage Clinical Trials In LMICs 3/6/2025

    Gates MRI's head of clinical supply discusses learnings and considerations that he keeps in mind for clinical trial supply chain/logistics.

  3. Streamlining Compliance With Pre-Clinical Safety Tests 3/4/2025

    As cell therapies advance, challenges in ensuring safe, scalable, and compliant production increase. Discover how to develop efficient strategies to maintain cell viability and functionality throughout the supply chain.

  4. Ensuring Patient Impact In Advanced Therapy Logistics 2/25/2025

    Revolutionize advanced therapy logistics by prioritizing patient impact at every step of the supply chain to ensure life-saving treatments are delivered with integrity and precision.

  5. Mapping The Future: Q&A With Mark Sawicki, Ph.D., On 2025 Trends In CGT 2/25/2025

    Learn how you can stay ahead of the evolving cell and gene therapy landscape by leveraging innovative solutions to support the continued growth and success of therapies in 2025 and beyond.

  6. Optimizing Storage Solutions For Allogeneic iPSCs 2/13/2025

    This timely discussion from Cell & Gene Live explored the latest advancements in automation and storage solutions, with a particular focus on tailored cryopreservation techniques for induced pluripotent stem cells (iPSCs).

  7. The Future Of Gene Therapy Logistics – A Pivotal Moment 2/4/2025

    Ensure the safe, reliable, and future-ready delivery of gene therapies with cutting-edge temperature-controlled logistics solutions.

  8. Supporting Compliance And Reducing Risk In Gene Therapy Logistics 2/4/2025

    Ensure the safe, compliant, and seamless delivery of gene therapies by leveraging advanced logistics solutions designed to meet stringent regulatory standards and mitigate risk at every stage.

  9. Reflecting On A Milestone Year For Cell And Gene Therapies 2/3/2025

    Examine the significant CGT advancements in 2024, including new approvals for solid tumors and diabetes treatments, as well as the role of AI and logistical improvements in scaling these therapies.

  10. Outsourcing To ISO 17025 Accredited Suppliers 1/28/2025

    Discover the advantages of outsourcing equipment calibration to ISO 17025 accredited suppliers, including cost efficiency and regulatory assurance, in our detailed analysis. Read more to transform your calibration processes.